Discontinuation report PEDIAPRED
Report ID | 205412 |
Drug Identification Number | 02230619 |
Brand name | PEDIAPRED |
Common or Proper name | PEDIAPRED |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | PREDNISOLONE |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | ORAL ORAL |
Packaging size | 120ml |
ATC code | H02AB |
ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | 2024-01-31 |
Actual discontinuation date | 2023-12-18 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | N/A |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-09-28 | English | Compare |
v2 | 2023-09-28 | French | Compare |
v3 | 2023-12-18 | English | Compare |
v4 | 2023-12-18 | French | Compare |
v5 | 2023-12-19 | English | Compare |
Showing 1 to 5 of 5